All peptides
Metabolic
Retatrutide
Triple-receptor agonist explored for next-generation weight management research.
Lyophilized vial
Retatrutide is a triple-receptor agonist targeting GIP, GLP-1, and glucagon pathways simultaneously. It represents a newer direction in metabolic peptide research aimed at amplifying weight-management effects.
Research focus: Next-Generation Weight Research
Early studies investigate how engaging three receptors influences fat loss and energy expenditure compared with established GLP-1 therapies. The molecule is a frequent point of comparison in fat-loss research.